MolecularMD Announces Three Presentations Highlighting Non-Invasive Biomarker Detection and NGS Validation at Upcoming Scientific Conferences
October 24, 2012 08:00 ET
|
MolecularMD
PORTLAND, OR--(Marketwire - Oct 24, 2012) - MolecularMD Corp. announced today that presentations pertaining to clinical validation of Next Generation Sequencing platforms and advances in...
MolecularMD Submits Premarketing Approval Application to the FDA for Its BCR-ABL T315I Mutation Test, a Companion Diagnostic to Ponatinib, an Investigational BCR-ABL Inhibitor
July 30, 2012 16:05 ET
|
MolecularMD
PORTLAND, OR--(Marketwire - Jul 30, 2012) - MolecularMD Corp. today announced that it has submitted its application for Premarket Approval (PMA) of the MolecularMD BCR-ABL T315I Mutation Test...
MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives
April 02, 2012 08:00 ET
|
MolecularMD
PORTLAND, OR--(Marketwire - Apr 2, 2012) - MolecularMD Corp. announces that it has closed a $6 Million Series B equity financing led by existing investor, Ballast Point Ventures, which is joined by...
MolecularMD Announces Issuance of Patent Covering Methods for Therapeutic Resistance Monitoring in Lung Cancer Patients
December 09, 2011 07:00 ET
|
MolecularMD
PORTLAND, OR--(Marketwire - Dec 9, 2011) - MolecularMD Corp. today announces the issuance of a patent titled "Methods and Compositions for Detecting a Drug Resistant EGFR Mutant." The newly issued...
MolecularMD Corp. Obtains Exclusive License From NYU and MSKCC for BRAF Melanoma Assay
October 18, 2010 07:00 ET
|
MolecularMD
PORTLAND, OR--(Marketwire - October 18, 2010) - MolecularMD Corp. announced today that it has entered into a licensing agreement with New York University (NYU) and Memorial Sloan-Kettering Cancer...
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
October 28, 2009 07:00 ET
|
MolecularMD
PORTLAND, OR--(Marketwire - October 28, 2009) - MolecularMD Corp announced today that it has
moved their core operations to a expanded dedicated facility with capacity
and functionality to support...